Alan Leong, Director of Research for BSR, interviews ViRexx Medical (AMEX:REX) CEO Lorne Tyrell and President Marc Canton . The interview updates the status of the OvaRex cancer vaccine as well as the Chimigen and Occlusin platforms.
At the time of the interview, one or more BSR staff members had a long position in REX. For more information, see the Disclosures section of this web site.
|
Interview and accompanying text © 2007, Biotech Stock Research, LLC |
|
